Alpha Tau Medical (DRTS) EBT (2021 - 2026)
Alpha Tau Medical (DRTS) posted EBT of $23.0 million for Q1 2026, up 88.56% sequentially from $12.2 million in Q4 2025, and up 167.11% YoY from $8.6 million in Q1 2025.
Alpha Tau Medical (DRTS) EBT (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported EBT for 6 years, with the latest figure at $23.0 million in Q1 2026.
- Quarterly EBT rose 167.11% year-over-year to $23.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.9 million (up 75.74% YoY) and the FY2025 annual result came in at $42.5 million, up 33.9% from the prior year.
- EBT advanced to $23.0 million in Q1 2026 per DRTS's latest filing, from $12.2 million in the prior quarter.
- Over five years, EBT peaked at $25.7 million in Q1 2022 and troughed at $2.0 million in Q2 2022.
- A 5-year average of $9.4 million and a median of $8.2 million in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2023: EBT sank 71.39% in 2022, then surged 334.87% in 2023.
- Over 5 years, EBT stood at $3.4 million in 2022, then soared by 116.83% to $7.4 million in 2023, then increased by 28.78% to $9.5 million in 2024, then increased by 28.47% to $12.2 million in 2025, then soared by 88.56% to $23.0 million in 2026.
- According to Business Quant data, EBT over the past three periods registered $23.0 million, $12.2 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | -91.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -91.48 Mn |
| Mar 31, 2026 | 22.95 Mn |
| Dec 31, 2025 | 12.17 Mn |
| Sep 30, 2025 | 11.69 Mn |
| Jun 30, 2025 | 10.05 Mn |
| Mar 31, 2025 | 8.59 Mn |
| Dec 31, 2024 | 9.47 Mn |
| Sep 30, 2024 | 6.92 Mn |
| Jun 30, 2024 | 7.37 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Dec 31, 2023 | 7.36 Mn |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | 8.67 Mn |
| Mar 31, 2023 | 8.17 Mn |
| Dec 31, 2022 | 3.39 Mn |
| Sep 30, 2022 | 2.61 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 25.74 Mn |
| Dec 31, 2021 | 3.80 Mn |
| Sep 30, 2021 | 4.80 Mn |